Cormorant Asset Management, Lp - Net Worth and Insider Trading

Over the past 18 months, Cormorant Asset Management, Lp made no insider transaction in Akouos Inc (AKUS). Other recent insider transactions involving Akouos Inc (AKUS) include a net purchase of 29,992,668 shares made by Kearny Acquisition Corp ,

In summary, during the past 3 months, insiders sold 0 shares of Akouos Inc (AKUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akouos Inc (AKUS) were sold and 29,992,668 shares were bought by its insiders, resulting in a net purchase of 29,992,668 shares.

Akouos Inc (AKUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Asset Management, Lp made no insider transaction in Avidity Biosciences Inc (RNA). Other recent insider transactions involving Avidity Biosciences Inc (RNA) include a net sale of 119,600 shares made by Arthur A Levin , a net sale of 195,092 shares made by Sarah Boyce , and a net sale of 41,616 shares made by Michael F Maclean .

In summary, during the past 3 months, insiders sold 237,641 shares of Avidity Biosciences Inc (RNA) in total and bought 0 shares, with a net sale of 237,641 shares. During the past 18 months, 362,502 shares of Avidity Biosciences Inc (RNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 362,502 shares.

Avidity Biosciences Inc (RNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Turning Point Therapeutics Inc (TPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Turning Point Therapeutics Inc (TPTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Turning Point Therapeutics Inc (TPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Asset Management, Lp made no insider transaction in Axonics Inc (AXNX). Other recent insider transactions involving Axonics Inc (AXNX) include a net sale of 66,432 shares made by Danny L. Dearen , a net sale of 78,838 shares made by Ford Alfred J Jr , and a net sale of 39,921 shares made by Karen Noblett .

In summary, during the past 3 months, insiders sold 0 shares of Axonics Inc (AXNX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 397,082 shares of Axonics Inc (AXNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 397,082 shares.

Axonics Inc (AXNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Constellation Pharmaceuticals Inc (CNST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Constellation Pharmaceuticals Inc (CNST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Constellation Pharmaceuticals Inc (CNST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Asset Management, Lp made no insider transaction in Kezar Life Sciences Inc (KZR). Other recent insider transactions involving Kezar Life Sciences Inc (KZR) include a net sale of 508,747 shares made by Morningside Venture Investments Ltd ,

In summary, during the past 3 months, insiders sold 0 shares of Kezar Life Sciences Inc (KZR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 508,747 shares of Kezar Life Sciences Inc (KZR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 508,747 shares.

Kezar Life Sciences Inc (KZR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Asset Management, Lp made no insider transaction in Kiniksa Pharmaceuticals Ltd (KNSA). Other recent insider transactions involving Kiniksa Pharmaceuticals Ltd (KNSA) include a net sale of 96,513 shares made by John Paolini , a net sale of 83,336 shares made by Sanj K Patel , and a net sale of 24,101 shares made by Michael R Megna .

In summary, during the past 3 months, insiders sold 108,277 shares of Kiniksa Pharmaceuticals Ltd (KNSA) in total and bought 0 shares, with a net sale of 108,277 shares. During the past 18 months, 225,909 shares of Kiniksa Pharmaceuticals Ltd (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 225,909 shares.

Kiniksa Pharmaceuticals Ltd (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Proteostasis Therapeutics Inc (PTI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Proteostasis Therapeutics Inc (PTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Proteostasis Therapeutics Inc (PTI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Asset Management, Lp made no insider transaction in Apellis Pharmaceuticals Inc (APLS). Other recent insider transactions involving Apellis Pharmaceuticals Inc (APLS) include a net sale of 301,781 shares made by Pascal Deschatelets , a net sale of 16,250 shares made by Alec Machiels , and a net sale of 551,287 shares made by Cedric Francois .

In summary, during the past 3 months, insiders sold 441,279 shares of Apellis Pharmaceuticals Inc (APLS) in total and bought 0 shares, with a net sale of 441,279 shares. During the past 18 months, 1,343,452 shares of Apellis Pharmaceuticals Inc (APLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,343,452 shares.

Apellis Pharmaceuticals Inc (APLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Asset Management, Lp made no insider transaction in Clearside Biomedical Inc (CLSD). Other recent insider transactions involving Clearside Biomedical Inc (CLSD) include a net purchase of 580,222 shares made by Bradford T Whitmore , a net purchase of 40,000 shares made by Nancy J Hutson , and a net sale of 38,030 shares made by George M Lasezkay .

In summary, during the past 3 months, insiders sold 0 shares of Clearside Biomedical Inc (CLSD) in total and bought 574,444 shares, with a net purchase of 574,444 shares. During the past 18 months, 80,830 shares of Clearside Biomedical Inc (CLSD) were sold and 774,222 shares were bought by its insiders, resulting in a net purchase of 693,392 shares.

Clearside Biomedical Inc (CLSD)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Cellectar Biosciences Inc (CLRB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cellectar Biosciences Inc (CLRB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cellectar Biosciences Inc (CLRB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Asset Management, Lp made no insider transaction in Yumanity Therapeutics Inc (YMTX). Other recent insider transactions involving Yumanity Therapeutics Inc (YMTX) include a net sale of 10,890 shares made by Richard Peters , a net sale of 3,116 shares made by Michael D Wyzga , and a net sale of 3,116 shares made by Devin Whittemore Smith .

In summary, during the past 3 months, insiders sold 0 shares of Yumanity Therapeutics Inc (YMTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 19,098 shares of Yumanity Therapeutics Inc (YMTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 19,098 shares.

Yumanity Therapeutics Inc (YMTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Asset Management, Lp made no insider transaction in Atea Pharmaceuticals Inc (AVIR). Other recent insider transactions involving Atea Pharmaceuticals Inc (AVIR) include a net sale of 56,910 shares made by Jean-pierre Sommadossi , a net sale of 41,666 shares made by Franklin M Berger , and a net sale of 15,870 shares made by Maria Arantxa Horga .

In summary, during the past 3 months, insiders sold 0 shares of Atea Pharmaceuticals Inc (AVIR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 168,614 shares of Atea Pharmaceuticals Inc (AVIR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 168,614 shares.

Atea Pharmaceuticals Inc (AVIR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Asset Management, Lp made no insider transaction in Prometheus Biosciences Inc (RXDX). Other recent insider transactions involving Prometheus Biosciences Inc (RXDX) include a net sale of 125,000 shares made by Mark C. Mckenna , a net sale of 30,000 shares made by Keith W Marshall , and a net sale of 865,000 shares made by Cedars Sinai Intellectual Property Co .

In summary, during the past 3 months, insiders sold 0 shares of Prometheus Biosciences Inc (RXDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,020,000 shares of Prometheus Biosciences Inc (RXDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,020,000 shares.

Prometheus Biosciences Inc (RXDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Asset Management, Lp made no insider transaction in Rain Oncology Inc (RAIN). Other recent insider transactions involving Rain Oncology Inc (RAIN) include a net purchase of 1,198,445 shares made by Kevin C Tang , a net purchase of 164,881 shares made by Franklin M Berger , and a net purchase of 1,710,358 shares made by Biotechnology Value Fund L P .

In summary, during the past 3 months, insiders sold 0 shares of Rain Oncology Inc (RAIN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,168,973 shares of Rain Oncology Inc (RAIN) were sold and 3,247,657 shares were bought by its insiders, resulting in a net purchase of 2,078,684 shares.

Rain Oncology Inc (RAIN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Asset Management, Lp made no insider transaction in Olema Pharmaceuticals inc (OLMA). Other recent insider transactions involving Olema Pharmaceuticals inc (OLMA) include a net sale of 278,181 shares made by Cyrus Harmon , a net sale of 44,370 shares made by David C. Myles , and a net sale of 8,742 shares made by Kovacs Shane William Charles .

In summary, during the past 3 months, insiders sold 60,000 shares of Olema Pharmaceuticals inc (OLMA) in total and bought 0 shares, with a net sale of 60,000 shares. During the past 18 months, 413,074 shares of Olema Pharmaceuticals inc (OLMA) were sold and 2,255,932 shares were bought by its insiders, resulting in a net purchase of 1,842,858 shares.

Olema Pharmaceuticals inc (OLMA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Asset Management, Lp made no insider transaction in Erasca Inc (ERAS). Other recent insider transactions involving Erasca Inc (ERAS) include a net purchase of 2,300,000 shares made by Jonathan E Lim , a net purchase of 70,000 shares made by Alexander W. Casdin , and a net purchase of 615,384 shares made by Bihua Chen .

In summary, during the past 3 months, insiders sold 0 shares of Erasca Inc (ERAS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Erasca Inc (ERAS) were sold and 3,025,384 shares were bought by its insiders, resulting in a net purchase of 3,025,384 shares.

Erasca Inc (ERAS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Asset Management, Lp made no insider transaction in Pyxis Oncology Inc (PYXS). Other recent insider transactions involving Pyxis Oncology Inc (PYXS) include a net purchase of 31,426 shares made by Pamela Ann Connealy , a net purchase of 10,000 shares made by Jitendra Wadhane , and a net purchase of 3,623,188 shares made by Pfizer Inc .

In summary, during the past 3 months, insiders sold 0 shares of Pyxis Oncology Inc (PYXS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 36,558 shares of Pyxis Oncology Inc (PYXS) were sold and 3,664,614 shares were bought by its insiders, resulting in a net purchase of 3,628,056 shares.

Pyxis Oncology Inc (PYXS)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Elevation Oncology Inc (ELEV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Elevation Oncology Inc (ELEV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Elevation Oncology Inc (ELEV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Asset Management, Lp made no insider transaction in Icosavax Inc (ICVX). Other recent insider transactions involving Icosavax Inc (ICVX) include a net sale of 268,263 shares made by Adam K. Simpson , a net sale of 35,241 shares made by Cassia Cearley , and a net sale of 123,374 shares made by Niranjan Kanesa-thasan .

In summary, during the past 3 months, insiders sold 0 shares of Icosavax Inc (ICVX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 514,269 shares of Icosavax Inc (ICVX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 514,269 shares.

Icosavax Inc (ICVX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Asset Management, Lp made 2 insider transaction in Immuneering Corp (IMRX) with a net sale of 1,309,091. Other recent insider transactions involving Immuneering Corp (IMRX) include a net purchase of 100,000 shares made by Peter Feinberg , a net purchase of 57,965 shares made by Ann E Berman , and a net purchase of 20,000 shares made by Benjamin J. Zeskind .

In summary, during the past 3 months, insiders sold 1,309,091 shares of Immuneering Corp (IMRX) in total and bought 197,083 shares, with a net sale of 1,112,008 shares. During the past 18 months, 1,309,091 shares of Immuneering Corp (IMRX) were sold and 197,083 shares were bought by its insiders, resulting in a net sale of 1,112,008 shares.

Immuneering Corp (IMRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Asset Management, Lp made no insider transaction in Aerovate Therapeutics Inc (AVTE). Other recent insider transactions involving Aerovate Therapeutics Inc (AVTE) include a net sale of 283,585 shares made by Benjamin T Dake , a net sale of 143,142 shares made by Timothy P Noyes , and a net sale of 58,255 shares made by Hunter Gillies .

In summary, during the past 3 months, insiders sold 203,125 shares of Aerovate Therapeutics Inc (AVTE) in total and bought 0 shares, with a net sale of 203,125 shares. During the past 18 months, 649,019 shares of Aerovate Therapeutics Inc (AVTE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 649,019 shares.

Aerovate Therapeutics Inc (AVTE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Asset Management, Lp made no insider transaction in Design Therapeutics Inc (DSGN). Other recent insider transactions involving Design Therapeutics Inc (DSGN) include a net purchase of 36,000 shares made by Rodney W Lappe , a net purchase of 2,235,000 shares made by Arsani William , and a net purchase of 900,000 shares made by Sr One Capital Fund I Aggregator Lp .

In summary, during the past 3 months, insiders sold 0 shares of Design Therapeutics Inc (DSGN) in total and bought 28,265 shares, with a net purchase of 28,265 shares. During the past 18 months, 0 shares of Design Therapeutics Inc (DSGN) were sold and 4,118,715 shares were bought by its insiders, resulting in a net purchase of 4,118,715 shares.

Design Therapeutics Inc (DSGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Monte Rosa Therapeutics Inc (GLUE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Monte Rosa Therapeutics Inc (GLUE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Monte Rosa Therapeutics Inc (GLUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Asset Management, Lp made no insider transaction in BioAtla Inc (BCAB). Other recent insider transactions involving BioAtla Inc (BCAB) include a net purchase of 15,700 shares made by Sylvia Mcbrinn , a net purchase of 90,800 shares made by Short Jay M Phd , and a net purchase of 27,495 shares made by Christian Vasquez .

In summary, during the past 3 months, insiders sold 0 shares of BioAtla Inc (BCAB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BioAtla Inc (BCAB) were sold and 153,995 shares were bought by its insiders, resulting in a net purchase of 153,995 shares.

BioAtla Inc (BCAB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Asset Management, Lp made no insider transaction in Vigil Neuroscience Inc (VIGL). Other recent insider transactions involving Vigil Neuroscience Inc (VIGL) include a net purchase of 4,000 shares made by Ivana Magovcevic-liebisch , and a net sale of 300 shares made by Spyridon Papapetropoulos .

In summary, during the past 3 months, insiders sold 0 shares of Vigil Neuroscience Inc (VIGL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 300 shares of Vigil Neuroscience Inc (VIGL) were sold and 4,000 shares were bought by its insiders, resulting in a net purchase of 3,700 shares.

Vigil Neuroscience Inc (VIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Asset Management, Lp made no insider transaction in Biomea Fusion Inc (BMEA). Other recent insider transactions involving Biomea Fusion Inc (BMEA) include a net sale of 1,000,000 shares made by A2a Pharmaceuticals, Inc. , a net purchase of 400,000 shares made by Cormorant Global Healthcare Master Fund, Lp , and a net purchase of 5,000 shares made by Hitchcock Michael J.m. .

In summary, during the past 3 months, insiders sold 0 shares of Biomea Fusion Inc (BMEA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,000,000 shares of Biomea Fusion Inc (BMEA) were sold and 409,100 shares were bought by its insiders, resulting in a net sale of 590,900 shares.

Biomea Fusion Inc (BMEA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Asset Management, Lp made no insider transaction in Verve Therapeutics Inc (VERV). Other recent insider transactions involving Verve Therapeutics Inc (VERV) include a net sale of 1,108 shares made by Allison Dorval , a net purchase of 1,800,000 shares made by Krishna Yeshwant , and a net sale of 1,514 shares made by Joan Nickerson .

In summary, during the past 3 months, insiders sold 1,514 shares of Verve Therapeutics Inc (VERV) in total and bought 0 shares, with a net sale of 1,514 shares. During the past 18 months, 3,487 shares of Verve Therapeutics Inc (VERV) were sold and 1,800,000 shares were bought by its insiders, resulting in a net purchase of 1,796,513 shares.

Verve Therapeutics Inc (VERV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Asset Management, Lp made no insider transaction in Ventyx Biosciences Inc (VTYX). Other recent insider transactions involving Ventyx Biosciences Inc (VTYX) include a net sale of 1,349,712 shares made by Nsv Partners Iii Lp , a net sale of 1,349,712 shares made by Somu Subramaniam , and a net sale of 628,526 shares made by Raju Mohan .

In summary, during the past 3 months, insiders sold 9,019 shares of Ventyx Biosciences Inc (VTYX) in total and bought 0 shares, with a net sale of 9,019 shares. During the past 18 months, 4,237,062 shares of Ventyx Biosciences Inc (VTYX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,237,062 shares.

Ventyx Biosciences Inc (VTYX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Asset Management, Lp made no insider transaction in Tyra Biosciences Inc (TYRA). Other recent insider transactions involving Tyra Biosciences Inc (TYRA) include a net sale of 276,298 shares made by Daniel Bensen , a net sale of 252,175 shares made by Todd Harris , and a net sale of 265,568 shares made by Mva Investors, Llc .

In summary, during the past 3 months, insiders sold 221,691 shares of Tyra Biosciences Inc (TYRA) in total and bought 0 shares, with a net sale of 221,691 shares. During the past 18 months, 794,041 shares of Tyra Biosciences Inc (TYRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 794,041 shares.

Tyra Biosciences Inc (TYRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Asset Management, Lp made no insider transaction in Kineta Inc (KA). Other recent insider transactions involving Kineta Inc (KA) include a net purchase of 12,301 shares made by Shawn Iadonato , a net purchase of 7,250 shares made by Raymond J. Bartoszek , and a net purchase of 4,397 shares made by Craig W. Philips .

In summary, during the past 3 months, insiders sold 0 shares of Kineta Inc (KA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,113 shares of Kineta Inc (KA) were sold and 50,250 shares were bought by its insiders, resulting in a net purchase of 44,137 shares.

Kineta Inc (KA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Asset Management, Lp made 4 insider transaction in Ambrx Biopharma Inc (AMAM) with a net purchase of 10,965,823.

In summary, during the past 3 months, insiders sold 0 shares of Ambrx Biopharma Inc (AMAM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ambrx Biopharma Inc (AMAM) were sold and 10,965,823 shares were bought by its insiders, resulting in a net purchase of 10,965,823 shares.

Ambrx Biopharma Inc (AMAM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Asset Management, Lp made no insider transaction in GreenLight Biosciences Holdings PBC (GRNA). Other recent insider transactions involving GreenLight Biosciences Holdings PBC (GRNA) include a net sale of 9,188,659 shares made by Cormorant Global Healthcare Master Fund, Lp ,

In summary, during the past 3 months, insiders sold 0 shares of GreenLight Biosciences Holdings PBC (GRNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,188,659 shares of GreenLight Biosciences Holdings PBC (GRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 9,188,659 shares.

GreenLight Biosciences Holdings PBC (GRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Environmental Impact Acquisition Corp (ENVIU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Environmental Impact Acquisition Corp (ENVIU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Environmental Impact Acquisition Corp (ENVIU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Asset Management, Lp made no insider transaction in MoonLake Immunotherapeutics (MLTX). Other recent insider transactions involving MoonLake Immunotherapeutics (MLTX) include a net purchase of 1,629,151 shares made by Bihua Chen , a net sale of 200,000 shares made by Kristian Reich , and a net sale of 184,740 shares made by Santos Da Silva Jorge .

In summary, during the past 3 months, insiders sold 384,740 shares of MoonLake Immunotherapeutics (MLTX) in total and bought 0 shares, with a net sale of 384,740 shares. During the past 18 months, 484,740 shares of MoonLake Immunotherapeutics (MLTX) were sold and 1,629,151 shares were bought by its insiders, resulting in a net purchase of 1,144,411 shares.

MoonLake Immunotherapeutics (MLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Asset Management, Lp made 1 insider transaction in Ambrx Biopharma Inc (AMAM) with a net purchase of 1,307,311. Other recent insider transactions involving Ambrx Biopharma Inc (AMAM) include a net sale of 50,012 shares made by Daniel J. O'connor , a net sale of 12,778 shares made by Sonja Nelson ,

In summary, during the past 3 months, insiders sold 0 shares of Ambrx Biopharma Inc (AMAM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 62,790 shares of Ambrx Biopharma Inc (AMAM) were sold and 1,307,311 shares were bought by its insiders, resulting in a net purchase of 1,244,521 shares.

Ambrx Biopharma Inc (AMAM)'s detailed insider trading history can be found in Insider Trading Tracker table.